How the fat composition in our bodies affects the resistance of Staphylococcus aureus to antibiotics

Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus

['FUNDING_R01'] · UNIVERSITY OF GEORGIA · NIH-10977063

This study is looking at how the fats in our bodies affect the growth of Staphylococcus aureus bacteria, including the tough-to-treat MRSA, to help find better ways to prevent and treat infections for patients like you.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF GEORGIA (nih funded)
Locations1 site (ATHENS, UNITED STATES)
Trial IDNIH-10977063 on ClinicalTrials.gov

What this research studies

This research investigates the relationship between the lipid composition in the human body and the susceptibility of Staphylococcus aureus, particularly focusing on both methicillin-resistant (MRSA) and methicillin-susceptible strains (MSSA). The study aims to understand how these bacteria utilize host-derived fatty acids for their growth and survival, which could lead to new strategies for preventing and treating infections. By examining the fatty acid content in various tissues, the research seeks to uncover mechanisms that contribute to antibiotic resistance. Patients may benefit from insights that could lead to more effective treatments for infections caused by these bacteria.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals who have experienced infections caused by Staphylococcus aureus, particularly those with recurrent or resistant infections.

Not a fit: Patients with infections caused by bacteria other than Staphylococcus aureus may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options for patients suffering from antibiotic-resistant Staphylococcus aureus infections.

How similar studies have performed: While the specific focus on host lipid composition and its impact on Staphylococcus aureus is relatively novel, previous studies have shown success in understanding bacterial resistance mechanisms, indicating potential for meaningful advancements.

Where this research is happening

ATHENS, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.